PIAS/SUMO: New partners in transcriptional regulation

Cellular and Molecular Life Sciences

Volumn 60, Issue 12, 2003, Pages 2561-2574

  Schmidt, D ^a   Muller S ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

Nuclear hormone receptors; p53; PIAS; PML nuclear bodies; STAT; SUMO; Transcription; Wnt

Indexed keywords

CELL NUCLEUS RECEPTOR; CYTOKINE; HORMONE RECEPTOR; PROTEIN; PROTEIN INHIBITOR; PROTEIN INHIBITOR OF ACTIVATED STAT; PROTEIN P53; STAT PROTEIN; SUMO PROTEIN; TRANSCRIPTION FACTOR; UBIQUITIN; UNCLASSIFIED DRUG; WNT PROTEIN;

CELL COMPARTMENTALIZATION; CELL FUNCTION; ENHANCER REGION; HORMONAL REGULATION; NONHUMAN; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN SYNTHESIS REGULATION; REVIEW; TRANSCRIPTION REGULATION;

ANIMALS; CELL NUCLEUS; GENE EXPRESSION REGULATION; HUMANS; PROTEIN INHIBITORS OF ACTIVATED STAT; PROTEINS; SUMO-1 PROTEIN; TRANSCRIPTION, GENETIC;

EID: 0346100493     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-003-3129-1     Document Type: Review

References (104)

1. Shuai K. (2000) Modulation of STAT signaling by STAT-interacting proteins. Oncogene 19: 2638-2644
2. Aravind L. and Koonin E. V. (2000) SAP - a putative DNA-binding motif involved in chromosomal organization. Trends Biochem. Sci. 25: 112-114
3. Kipp M., Gohring F., Ostendorp T., van Drunen C. M., van Driel R., Przybylski M. et al. (2000) SAF-Box, a conserved protein domain that specifically recognizes scaffold attachment region DNA. Mol. Cell Biol. 20: 7480-7489
4. Tan J. A., Hall S. H., Hamil K. G., Grossman G., Petrusz P. and French F. S. (2002) Protein inhibitors of activated STAT resemble scaffold attachment factors and function as interacting nuclear receptor coregulators. J. Biol. Chem. 277: 16993-17001
5. Sachdev S., Bruhn L., Sieber H., Pichler A., Melchior F. and Grosschedl R. (2001) PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev. 15: 3088-3103
6. Hari K. L., Cook K. R. and Karpen G. H. (2001) The Drosophila Su(var) 2-10 locus regulates chromosome structure and function and encodes a member of the PIAS protein family. Genes Dev. 15: 1334-1348
7. Hochstrasser M. (2001) SP-RING for SUMO: new functions bloom for a ubiquitin-like protein. Cell 107: 5-8
8. Jackson P. K. (2001) A new RING for SUMO: wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases. Genes Dev. 15: 3053-3058
9. Joazeiro C. A. and Weissman A. M. (2000) RING finger proteins: mediators of ubiquitin ligase activity. Cell 102: 549-552
10. Aravind, L. and Koonin, E. V. (2000) The U box is a modified RING finger - a common domain in ubiquitination. Curr. Biol. 10: R132-134
11. Ohi M. D., Vander Kooi C. W., Rosenberg J. A., Chazin, W. J. and Gould K. L. (2003) Structural insights into the U-box, a domain associated with multi-ubiquitination. Nat. Struct. Biol. 3: 3
12. Johnson E. S. and Gupta A. A. (2001) An E3-like factor that promotes SUMO conjugation to the yeast septins. Cell 106: 35-744
13. Takahashi Y., Kahyo T., Toh E. A., Yasuda H. and Kikuchi Y. (2001) Yeast Ull1/Siz1 is a novel SUMO1/Smt3 ligase for septin components and functions as an adaptor between conjugating enzyme and substrates. J. Biol. Chem. 276: 48973-48977
14. Takahashi Y., Toh-e A. and Kikuchi Y. (2001) A novel factor required for the SUMO1/Smt3 conjugation of yeast septins. Gene 275: 223-231
15. Melchior F. (2000) Sumo nonclassical ubiquitin. Annu. Rev. Cell. Dev. Biol. 16: 591-626
16. Muller S., Hoege C., Pyrowolakis G. and Jentsch S. (2001) SUMO, ubiquitin's mysterious cousin. Nat. Rev. Mol. Cell Biol. 2: 202-210
17. Weissman A. M. (2001) Themes and variations on ubiquitylation. Nat. Rev. Mol. Cell Biol. 2: 169-178
18. Pichler A., Gast A., Seeler J. S., Dejean A. and Melchior F. (2002) The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 108: 109-120
19. Kahyo T., Nishida T. and Yasuda H. (2001) Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol. Cell 8: 713-718
20. Schmidt D. and Muller S. (2002) Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. Proc. Natl. Acad. Sci. USA 99: 2872-2877
21. Kotaja N., Karvonen U., Janne O. A. and Palvimo J. J. (2002) PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol. Cell Biol. 22: 5222-5234
22. Bernier-Villamor V., Sampson D. A., Matunis M. J. and Lima C. D. (2002) Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1. Cell 108: 345-356
23. Sapetschnig A., Rischitor G., Braun H., Doll A., Schergaut M., Melchior F. et al. (2002) Transcription factor Sp3 is silenced through SUMO modification by PIAS1. EMBO J. 21: 5206-5215
24. Minty A., Dumont X., Kaghad M. and Caput D. (2000) Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif. J. Biol. Chem. 275: 36316-36323
25. Desterro J. M., Rodriguez M. S. and Hay R. T. (1998) SUMO-1 modification of IκBα inhibits NF-κB activation. Mol. Cell 2: 233-239
26. Hoege C., Pfander B., Moldovan G. L., Pyrowolakis G. and Jentsch S. (2002) RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 419: 135-141
27. Matunis M. J., Wu J. and Blobel G. (1998) SUMO-1 modification and its role in targeting the Ran GTPase-activating protein, RanGAP1, to the nuclear pore complex. J. Cell. Biol. 140: 499-509
28. Mahajan R., Delphin C., Guan T., Gerace L. and Melchior F. (1997) A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 88: 97-107
29. Rodel B., Tavassoli K., Karsunky H., Schmidt T., Bachmann M., Schaper F. et al. (2000) The zinc finger protein Gfi-1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3. EMBO J. 19: 5845-5855
30. Seeler J. S. and Dejean A. (2001) SUMO: of branched proteins and nuclear bodies. Oncogene 20: 7243-7249
31. Zhong S., Salomoni P. and Pandolfi P. P. (2000) The transcriptional role of PML and the nuclear body. Nat. Cell Biol. 2: E85-90
32. Levy D. E. and Darnell J. E. Jr (2002) Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 3: 651-662
33. Aaronson D. S. and Horvath C. M. (2002) A road map for those who know JAK-STAT. Science 296: 1653-1655
34. O'Shea J. J., Gadina M. and Schreiber R. D. (2002) Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell 109: S121-131
35. Starr R. and Hilton D. J. (1999) Negative regulation of the JAK/STAT pathway. Bioessays 21: 47-52
36. Hilton D. J. (1999) Negative regulators of cytokine signal transduction. Cell. Mol. Life Sci. 55: 1568-1577
37. Liu B., Liao J., Rao X., Kushner S. A., Chung C. D., Chang D. D. et al. (1998) Inhibition of Statl-mediated gene activation by PIAS1. Proc. Natl. Acad. Sci. USA 95: 10626-10631
38. Mowen K. A., Tang J., Zhu W., Schurter B. T., Shuai K., Herschman H. R. et al. (2001) Arginine methylation of STAT1 modulates IFNalpha/beta-induced transcription. Cell 104: 731-741
39. Liao J., Fu Y. and Shuai K. (2000) Distinct roles of the NH2-and COOH-terminal domains of the protein inhibitor of activated signal transducer and activator of transcription (STAT) 1 (PIAS1) in cytokine-induced PIAS1-Stat1 interaction. Proc. Natl. Acad. Sci. USA 97: 5267-5272
40. Chung C. D., Liao J., Liu B., Rao X., Jay P., Berta P. et al. (1997) Specific inhibition of Stat3 signal transduction by PIAS3. Science 278: 1803-1805
41. Rycyzyn M. A. and Clevenger C. V. (2002) The intranuclear prolactin/cyclophilin B complex as a transcriptional inducer. Proc. Natl. Acad. Sci. USA 99: 6790-6795
42. Liu B., Gross M., ten Hoeve J. and Shuai K. (2001) A transcriptional corepressor of Stat1 with an essential LXXLL signature motif. Proc. Natl. Acad. Sci. USA 98: 3203-3207
43. Nakagawa K. and Yokosawa H. (2002) PIAS3 induces SUMO-1 modification and transcriptional repression of IRF-1. FEBS Lett. 530: 204-208
44. Moon R. T., Bowerman B., Boutros M. and Perrimon N. (2002) The promise and perils of Wnt signaling through beta-catenin. Science 296: 1644-1646
45. Levy C., Nechushtan H. and Razin E. (2002) A new role for the STAT3 inhibitor, PIAS3: a repressor of microphthalmia transcription factor. J. Biol. Chem. 277: 1962-1966
46. Yasumoto K., Takeda K., Saito H., Watanabe K., Takahashi K. and Shibahara S. (2002) Microphthalmia-associated transcription factor interacts with LEF-1, a mediator of Wnt signaling. EMBO J. 21: 2703-2714
47. Xu W., Gong L., Haddad M. M., Bischof O., Campisi J., Yeh E. T. et al. (2000) Regulation of microphthalmia-associated transcription factor MITF protein levels by association with the ubiquitin-conjugating enzyme hUBC9. Exp. Cell Res. 255: 135-143
48. 8 Kobayashi M., Kishida S., Fukui A., Michiue T., Miyamoto Y., Okamoto T. et al. (2002) Nuclear localization of Duplin, a beta-catenin-binding protein, is essential for its inhibitory activity on the Wnt signaling pathway. J. Biol. Chem. 277: 5816-5822
49. Vogelstein B., Lane D. and Levine A. J. (2000) Surfing the p53 network. Nature 408: 307-310
50. Prives C. (1998) Signaling to p53: breaking the MDM2-p53 circuit. Cell 95: 5-8
51. Jayaraman L. and Prives C. (1999) Covalent and noncovalent modifiers of the p53 protein. Cell. Mol. Life Sci. 55: 76-87
52. Barlev N. A., Liu L., Chehab N. H., Mansfield K., Harris K. G., Halazonetis T. D. et al. (2001) Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Mol. Cell 8: 1243-1254
53. Rodriguez M. S., Desterro J. M., Lain S., Midgley C. A., Lane D. P. and Hay R. T. (1999) SUMO-1 modification activates the transcriptional response of p53. EMBO J. 18: 6455-6461
54. Muller S., Berger M., Lehembre F., Seeler J. S., Haupt Y. and Dejean A. (2000) c-Jun and p53 activity is modulated by SUMO-1 modification. J. Biol. Chem. 275: 13321-13329
55. Gostissa M., Hengstermann A., Fogal V., Sandy P., Schwarz S. E., Scheffner M. et al. (1999) Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J. 18: 6462-6471
56. Nelson V., Davis G. E. and Maxwell S. A. (2001) A putative protein inhibitor of activated STAT (PIASy) interacts with p53 and inhibits p53-mediated transactivation but not apoptosis. Apoptosis 6: 221-234
57. Gallagher W. M., Argentini M., Sierra V., Bracco L., Debussche L. and Conseiller E. (1999) MBP1: a novel mutant p53-specific protein partner with oncogenic properties. Oncogene 18: 3608-3616
58. Fogal V., Gostissa M., Sandy P., Zacchi P., Sternsdorf T., Jensen K. et al. (2000) Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J. 19: 6185-6195
59. Miyauchi Y., Yogosawa S., Honda R., Nishida T. and Yasuda H. (2002) Sumoylation of Mdm2 by protein inhibitor of activated STAT (PIAS) and RanBP2 enzymes. J. Biol. Chem. 277: 50131-50136
60. Megidish T., Xu J. H. and Xu C. W. (2002) Activation of p53 by protein inhibitor of activated Stat1 (PIAS1). J. Biol. Chem. 277: 8255-8259
61. Wible B. A., Wang L., Kuryshev Y. A., Basu A., Haldar S. and Brown A. M. (2002) Increased K+ efflux and apoptosis induced by the potassium channel modulatory protein KChAP/PIAS3β in prostate cancer cells. J. Biol. Chem. 277: 17852-17862
62. Beato M., Herrlich P. and Schutz G. (1995) Steroid hormone receptors: many actors in search of a plot. Cell 83: 851-857
63. Rosenfeld M. G. and Glass C. K. (2001) Coregulator codes of transcriptional regulation by nuclear receptors. J. Biol. Chem. 276: 36865-36868
64. Moilanen A. M., Karvonen U., Poukka H., Yan W., Toppari J., Janne O. A. et al. (1999) A testis-specific androgen receptor coregulator that belongs to a novel family of nuclear proteins. J. Biol. Chem. 274: 3700-3704
65. Junicho A., Matsuda T., Yamamoto T., Kishi H., Korkmaz K., Saatcioglu F. et al. (2000) Protein inhibitor of activated STAT3 regulates androgen receptor signaling in prostate carcinoma cells. Biochem. Biophys. Res. Commun. 278: 9-13
66. Gross M., Liu B., Tan J., French F. S., Carey M. and Shuai K. (2001) Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells. Oncogene 20: 3880-3887
67. Li P., Yu X., Ge K., Melamed J., Roeder R. G. and Wang Z. (2002) Heterogeneous expression and functions of androgen receptor co-factors in primary prostate cancer. Am. J. Pathol. 161: 1467-1474
68. Kotaja N., Aittomaki S., Silvennoinen O., Palvimo J. J. and Janne O. A. (2000) ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation. Mol. Endocrinol. 14: 1986-2000
69. Kotaja N., Vihinen M., Palvimo J. J. and Janne O. A. (2002) Androgen receptor-interacting protein 3 and other PIAS proteins cooperate with glucocorticoid receptor-interacting protein 1 in steroid receptor-dependent signaling. J. Biol. Chem. 277: 17781-17788
70. Jimenez-Lara A. M., Heine M. J. and Gronemeye, H. (2002) PIAS3 (protein inhibitor of activated STAT-3) modulates the transcriptional activation mediated by the nuclear receptor coactivator TIF2. FEBS Lett. 526: 142-146
71. Kotaja N., Karvonen U., Janne O. A. and Palvimo J. J. (2002) The nuclear receptor interaction domain of GRIP1 is modulated by covalent attachment of SUMO-1. J. Biol. Chem. 277: 30283-30288
72. Chauchereau A., Amazit L., Quesne M., Guiochon-Mantel A. and Milgrom E. (2003) Sumoylation of the progesterone receptor and of the steroid receptor coactivator SRC-1. J. Biol. Chem. 278: 12335-12343
73. Nishida T. and Yasuda H. (2002) PIAS1 and PIASxα function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription. J. Biol. Chem. 277: 41311-41317
74. Poukka H., Karvonen U., Janne O. A. and Palvimo J. J. (2000) Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). Proc. Natl. Acad. Sci. USA 97: 14145-14150
75. Abdel-Hafiz H., Takimoto G. S., Tung L. and Horwitz K. B. (2002) The inhibitory function in human progesterone receptor N termini binds SUMO-1 protein to regulate autoinhibition and transrepression. J. Biol. Chem. 277: 33950-33956
76. Tian S., Poukka H., Palvimo J. J. and Janne O. A. (2002) Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor. Biochem. J. 367: 907-911
77. Ross S., Best J. L., Zon, L. I. and Gill G. (2002) SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization. Mol. Cell 10: 831-842
78. Won J., Yim J. and Kim T. K. (2002) Sp1 and Sp3 recruit histone deacetylase to repress transcription of human telomerase reverse transcriptase (hTERT) promoter in normal human somatic cells. J. Biol. Chem. 277: 38230-38238
79. Sun J. M., Chen H. Y., Moniwa M., Litchfield D. W., Seto E. and Davie J. R. (2002) The transcriptional repressor Sp3 is associated with CK2-phosphorylated histone deacetylase 2. J. Biol. Chem. 277: 35783-35786
80. Khan M. M., Nomura T., Kim H., Kaul S. C., Wadhwa R., Shinagawa T. et al. (2001) Role of PML and PML-RARalpha in Madmediated transcriptional repression. Mol. Cell 7: 1233-1243
81. Tussie-Luna M. I., Bayarsaihan D., Seto E., Ruddle F. H. and Roy A. L. (2002) Physical and functional interactions of histone deacetylase 3 with TFII-I family proteins and PIASxβ. Proc. Natl. Acad. Sci. USA 99: 12807-12812
82. Luo J., Su F., Chen D., Shiloh A. and Gu W. (2000) Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature 408: 377-381
83. Juan L. J., Shia W. J., Chen M. H., Yang W. M., Seto E., Lin Y. S. et al. (2000) Histone deacetylases specifically down-regulate p53-dependent gene activation. J. Biol. Chem. 275: 20436-20443
84. Langley E., Pearson M., Faretta M., Bauer U. M., Frye R. A., Minucci S. et al. (2002) Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J. 21: 2383-2396
85. Kawasaki A., Matsumura I., Kataoka Y., Takigawa E., Nakajima K. and Kanakura Y. (2002) Opposing effects of PML and PML/RARα on STAT3 activity. Blood 27: 27
86. Bies J., Markus J. and Wolff L. (2002) Covalent attachment of the SUMO-1 protein to the negative regulatory domain of the c-Myb transcription factor modifies its stability and transactivation capacity. J. Biol. Chem. 277: 8999-9009
87. Dahle O., Andersen T., Nordgard O., Matre V., Del Sal G. and Gabrielsen O. S. (2003) Transactivation properties of c-Myb are critically dependent on two SUMO-1 acceptor sites that are conjugated in a PIASy enhanced manner. Eur. J. Biochem. 270: 1338-1348
88. Subramanian L., Benson M. D. and Iniguez-Lluhi J. A. (2003) A synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy through Its PIASy-enhanced modification by SUMO-1 or SUMO-3. J. Biol. Chem. 278: 9134-9141
89. Kim J., Cantwell C. A., Johnson P. F., Pfarr C. M. and Williams S. C. (2002) Transcriptional activity of CCAAT/enhancer-binding proteins is controlled by a conserved inhibitory domain that is a target for sumoylation. J. Biol. Chem. 277: 38037-38044
90. Best J. L., Ganiatsas S., Agarwal S., Changou A., Salomoni P., Shirihai O. et al. (2002) SUMO-1 protease-1 regulates gene transcription through PML. Mol. Cell 10: 843-855
91. Muratani M. and Tansey W. P. (2003) How the ubiquitin-proteasome system controls transcription. Nat. Rev. Mol. Cell Biol. 4: 192-201
92. Baumann C. T., Ma H., Wolford R., Reyes J. C., Maruvada P., Lim C. et al. (2001) The glucocorticoid receptor interacting protein 1 (GRIP1) localizes in discrete nuclear foci that associate with ND10 bodies and are enriched in components of the 26S proteasome. Mol. Endocrinol. 15: 485-500
93. Rivera O. J., Song C. S., Centonze V. E., Lechleiter J. D., Chatterjee B. and Roy A. K. (2003) Role of the promyelocytic leukemia body in the dynamic interaction between the androgen receptor and steroid receptor coactivator-1 in living cells. Mol. Endocrinol. 17: 128-140
94. Gottlicher M., Heck S. and Herrlich P. (1998) Transcriptional cross-talk, the second mode of steroid hormone receptor action. J. Mol. Med. 76: 480-489
95. Tahirov T. H., Sato K., Ichikawa-Iwata E., Sasaki M., Inoue-Bungo T., Shiina M. et al. (2002) Mechanism of c-Myb-C/EBP beta cooperation from separated sites on a promoter. Cell 108: 57-70
96. Courey A. J. (2001) Cooperativity in transcriptional control. Curr. Biol. 11: R250-252
97. Kirsh O., Seeler J. S., Pichler A., Gast A., Muller S., Miska E. et al. (2002) The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase. EMBO J. 21: 2682-2691
98. Tussie-Luna M. I., Michel B., Hakre S. and Roy A. L. (2002) The SUMO ubiquitin-protein isopeptide ligase family member Miz1/PIASxβ/Siz2 is a transcriptional cofactor for TFII-I. J. Biol. Chem. 277: 43185-43193
99. Weiskirchen R., Moser M., Weiskirchen S., Erdel M., Dahmen S., Buettner R. et al. (2001) LIM-domain protein cysteine-and glycine-rich protein 2 (CRP2) is a novel marker of hepatic stellate cells and binding partner of the protein inhibitor of activated STAT1. Biochem. J. 359: 485-496
100. Valdez B. C., Henning D., Perlaky L., Busch R. K. and Busch H. (1997) Cloning and characterization of Gu/RH-II binding protein. Biochem. Biophys. Res. Commun. 234: 335-340
101. Wu L., Wu H., Ma L., Sangiorgi F., Wu N., Bell J. R. et al. (1997) Mizl, a novel zinc finger transcription factor that interacts with Msx2 and enhances its affinity for DNA. Mech. Dev. 65: 3-17
102. Zentner M. D., Lin H. H., Deng H. T., Kim K. J., Shih H. M. and Ann D. K. (2001) Requirement for high mobility group protein HMGI-C interaction with STAT3 inhibitor PIAS3 in repression of alpha-subunit of epithelial Na+ channel (alpha-ENaC) transcription by Ras activation in salivary epithelial cells. J. Biol. Chem. 276: 29805-29814
103. Cho S. Y., Jeon J. W., Lee S. H. and Park S. S. (2000) p67 isoform of mouse disabled 2 protein acts as a transcriptional activator during the differentiation of F9 cells. Biochem. J. 3: 645-650
104. Takahashi K., Taira T., Niki T., Seino C., Iguchi-Ariga S. M. and Ariga H. (2001) DJ-1 positively regulates the androgen receptor by impairing the binding of PIASxa to the receptor. J. Biol. Chem. 26: 26